162 related articles for article (PubMed ID: 27034428)
1. Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A.
Lai JD; Moorehead PC; Sponagle K; Steinitz KN; Reipert BM; Hough C; Lillicrap D
Blood; 2016 Jun; 127(26):3439-49. PubMed ID: 27034428
[TBL] [Abstract][Full Text] [Related]
2. Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice.
Wroblewska A; van Haren SD; Herczenik E; Kaijen P; Ruminska A; Jin SY; Zheng XL; van den Biggelaar M; ten Brinke A; Meijer AB; Voorberg J
Blood; 2012 May; 119(22):5294-300. PubMed ID: 22498747
[TBL] [Abstract][Full Text] [Related]
3. B cell-activating factor modulates the factor VIII immune response in hemophilia A.
Doshi BS; Rana J; Castaman G; Shaheen MA; Kaczmarek R; Butterfield JS; Meeks SL; Leissinger C; Biswas M; Arruda VR
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33651716
[TBL] [Abstract][Full Text] [Related]
4. High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors.
Hausl C; Ahmad RU; Sasgary M; Doering CB; Lollar P; Richter G; Schwarz HP; Turecek PL; Reipert BM
Blood; 2005 Nov; 106(10):3415-22. PubMed ID: 16091456
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Potential Feasibility of Intra-Articular Adeno-Associated Virus-Mediated Gene Therapy for Hemophilia Arthropathy.
Zhang F; Yan X; Li M; Hua B; Xiao X; Monahan PE; Sun J
Hum Gene Ther; 2020 Apr; 31(7-8):448-458. PubMed ID: 32079420
[TBL] [Abstract][Full Text] [Related]
6. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A.
Madoiwa S; Yamauchi T; Kobayashi E; Hakamata Y; Dokai M; Makino N; Kashiwakura Y; Ishiwata A; Ohmori T; Mimuro J; Sakata Y
J Thromb Haemost; 2009 May; 7(5):811-24. PubMed ID: 19220731
[TBL] [Abstract][Full Text] [Related]
7. Exposure to factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward factor VIII challenge in hemophilia A mice.
Gaitonde P; Ramakrishnan R; Chin J; Kelleher RJ; Bankert RB; Balu-Iyer SV
J Biol Chem; 2013 Jun; 288(24):17051-6. PubMed ID: 23649621
[TBL] [Abstract][Full Text] [Related]
8. Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice.
Jing W; Chen J; Cai Y; Chen Y; Schroeder JA; Johnson BD; Cui W; Shi Q
Blood Adv; 2019 Oct; 3(20):3099-3110. PubMed ID: 31648333
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus-Mediated Gene Therapy in a Hemophilia A Mouse Model.
Sun J; Yuan Z; Abajas YL; Szollosi DE; Hu G; Hua B; Xiao X; Li C
Hum Gene Ther; 2018 Mar; 29(3):381-389. PubMed ID: 28922951
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
11. The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity.
Chen Y; Schroeder JA; Chen J; Luo X; Baumgartner CK; Montgomery RR; Hu J; Shi Q
Blood; 2016 Mar; 127(10):1346-54. PubMed ID: 26668132
[TBL] [Abstract][Full Text] [Related]
12. Platelet VIII pack evades immune detection.
Ragni MV
Blood; 2016 Mar; 127(10):1222-4. PubMed ID: 26965921
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
Reipert BM; van Helden PM; Schwarz HP; Hausl C
Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
[TBL] [Abstract][Full Text] [Related]
14. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
Madoiwa S; Kobayashi E; Kashiwakura Y; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
Haemophilia; 2012 May; 18(3):e323-30. PubMed ID: 22044430
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to recombinant human coagulation factor VIII in a new rat model of severe hemophilia A.
Lövgren KM; Søndergaard H; Skov S; Weldingh KN; Tranholm M; Wiinberg B
J Thromb Haemost; 2016 Apr; 14(4):747-56. PubMed ID: 26784374
[TBL] [Abstract][Full Text] [Related]
16. Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice.
Meslier Y; André S; Teyssandier M; Kaveri SV; Lacroix-Desmazes S
Immunology; 2010 Dec; 131(4):549-55. PubMed ID: 20673239
[TBL] [Abstract][Full Text] [Related]
17. High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.
Batsuli G; Deng W; Healey JF; Parker ET; Baldwin WH; Cox C; Nguyen B; Kahle J; Königs C; Li R; Lollar P; Meeks SL
Blood; 2016 Oct; 128(16):2055-2067. PubMed ID: 27381905
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
Qadura M; Waters B; Burnett E; Chegeni R; Hough C; Othman M; Lillicrap D
Haemophilia; 2011 Mar; 17(2):288-95. PubMed ID: 21091850
[TBL] [Abstract][Full Text] [Related]
19. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory antibodies in hemophilia A.
Pratt KP
Curr Opin Hematol; 2012 Sep; 19(5):399-405. PubMed ID: 22814650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
